Fleischmann, Roy M <br/><br/>
A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis.  [electronic resource] 

 -  Arthritis research & therapy  08 2018 
 - 178 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1478-6362 
<br/><br/><label>Standard No.: </label>10.1186/s13075-018-1676-y  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab--therapeutic use<br/>Adult<br/>Aged<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Biosimilar Pharmaceuticals--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged